Comparative Effectiveness of Telemedicine in Primary Care

CompletedOBSERVATIONAL
Enrollment

33,100

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
AsthmaChronic Obstructive Pulmonary Disease (COPD)Congestive Heart FailureDiabetesHypertension
Interventions
OTHER

Exposure to telemedicine, after the onset of the pandemic

The exposure of interest was the switch to primary care telemedicine prompted by the COVID-19 epidemic

Trial Locations (4)

10029

Mount Sinai, New York

10065

Weill Cornell Medicine, New York

27599

University of North Carolina, Chapel Hill

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT04684836 - Comparative Effectiveness of Telemedicine in Primary Care | Biotech Hunter | Biotech Hunter